Ischemic Heart Disease

Schwartz1

  • 1Department of Medicine, Buffalo General Hospital, 100 High Street, Buffalo, NY 14203, USA.

Insights

Effective treatment for ischemic heart disease involves symptom relief and preventing major cardiac events. Current medical therapies, including lifestyle changes and medications, significantly improve patient outcomes and reduce the need for procedures.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Ischemic heart disease (IHD) management aims to alleviate symptoms, prevent acute coronary syndromes like unstable angina or myocardial infarction, and extend patient survival.
  • Therapeutic strategies have evolved significantly over four decades, with initial emphasis on revascularization procedures.

Purpose of the Study:

  • To highlight the impact of medical therapy in managing ischemic heart disease.
  • To emphasize the role of lifestyle modifications and pharmacologic agents in improving patient prognosis and reducing intervention rates.

Main Methods:

  • Review of established and emerging therapeutic strategies for ischemic heart disease.
  • Analysis of the impact of lifestyle changes (e.g., smoking cessation) and pharmacologic treatments (e.g., aspirin, beta-blockers, lipid-lowering agents) on clinical outcomes.

Main Results:

  • Coronary artery bypass surgery and percutaneous coronary interventions remain important but are complemented by effective medical management.
  • Appropriate medical therapy, including lifestyle changes and specific drug classes, demonstrably reduces acute ischemic events and prolongs life in patients with coronary artery disease.
  • Medical therapy can significantly decrease the necessity for revascularization procedures.

Conclusions:

  • Current medical therapies, encompassing lifestyle interventions and pharmacologic agents, are crucial for managing ischemic heart disease and improving long-term outcomes.
  • Ensuring all appropriate patients receive optimal medical therapy is paramount, even as research into new treatments for atherosclerosis progresses.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...